Active, not recruitingNCT05206617
3 Year Follow up on ANO5 Patients
Studying Anoctamin-5-related limb-girdle muscular dystrophy R12
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Rigshospitalet, Denmark
- Intervention
- No intervention - pure observational study(other)
- Enrollment
- 17 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2018 – 2026
Study locations (1)
- Copenhagen Neuromuscular Center, Copenhagen, Capital Region, Denmark
Collaborators
Funding: Toyota Foundation · The Hede Nielsen Family Foundation · Funding: Grosserer L. F. Foghts Foundation · Funding: Torben og Alice Frimodts Foundation · Funding: Aase og Ejnar Danielsens Foundation · Funding: Oda og Hans Svenningens Foundation · Funding: Torkild Steensbecks Legat · Funding: Foundation for research in Neurology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05206617 on ClinicalTrials.govOther trials for Anoctamin-5-related limb-girdle muscular dystrophy R12
Additional recruiting or active studies for the same condition.
See all trials for Anoctamin-5-related limb-girdle muscular dystrophy R12 →